A profitable company with steady sales.
Facts from SEC filings, not a recommendation.
From TR's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Last 12 months: $734.7M, up 1.6% from the 12 months before. Over 5 years, sales grew about 9.2% a year.
Move the sliders to your own view of TR. Starting points are the company's recent numbers.
What today's price needs: with a 13% margin and a 27x P/E, sales would have to grow about 0.1% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
Forum talk counts mentions of TR in popular online stock forums, a slice of the internet rather than all of it. Company lookups show interest in the company itself, which can come from news that isn't about the stock. Attention isn't quality.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: debt under half of equity, share count not growing. A checklist is a starting point for research, not a verdict.
From the press release, checked against last year's SEC filing. Cash flow and share count update with the 10-Q.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
Institutions cut 3.6% from their holdings. 132 bought, 101 sold.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
23,000 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page